ARCHIVES

Genasense Added To Chemo Improves Responses in CLL

This article is from The Cancer Letter archive.

Vol. 27 No. 12 | December 31, 2004

Download PDF Visit The Full Archive

Related Articles

Leyland-Jones Named Director of Emory’s Winship Cancer Institute

November 17, 2006

NCI “Leadership Vacuum” Deepened?

December 22, 1994

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products

January 16, 2009

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

May 31, 2013

In Brief: Carbone To Leave NCI for Wisconsin ACS’ Holleb Says Tobacco Industry Tries to Hide Ad Warning

October 3, 1975